Heartfelt Technologies
8
2
3
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
The HEARTFELT Study
Role: lead
Remote Monitoring of Ambulatory Intravenous Diuretics in Heart Failure
Role: lead
HF-TRACK: A UK RCT of an Passive Heart Failure Monitoring and Tracking Device
Role: lead
Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk
Role: lead
Foot Oedema Observed Over Time Study
Role: lead
Lancashire Objective Volume Evaluation of Leg Oedema in Heart Failure Second Pilot
Role: lead
Lancashire Objective Volume Evaluation of Leg Oedema in Heart Failure
Role: lead
Feasibility Study of a New Peripheral Oedema Monitor for Heart Failure
Role: lead
All 8 trials loaded